• 1. Alt-proteins: A promising future
• 2. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 3. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 4. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 5. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aminobenzenesulfonamides
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzenesulfonamides Aminobenzenesulfonamides

Benzenesulfonamide,3-amino-4-(butylamino)- (CAS No. 1565-51-1): A Comprehensive Overview in Modern Chemical Research

Benzenesulfonamide,3-amino-4-(butylamino)-, identified by its CAS number 1565-51-1, is a significant compound in the realm of pharmaceutical and chemical research. This sulfonamide derivative has garnered considerable attention due to its versatile applications and structural properties that make it a valuable intermediate in the synthesis of various bioactive molecules.

The compound belongs to the class of sulfonamides, which are well-known for their broad spectrum of biological activities. Sulfonamides have been extensively studied for their antimicrobial, anti-inflammatory, and anticancer properties. The presence of both amino and butylamino groups in Benzenesulfonamide,3-amino-4-(butylamino)- enhances its reactivity and potential utility in drug design. This unique structural feature allows for further functionalization, making it a crucial building block in medicinal chemistry.

In recent years, there has been a surge in research focused on developing novel sulfonamide-based therapeutics. The structural motif of Benzenesulfonamide,3-amino-4-(butylamino)- has been explored in the design of molecules targeting various diseases. For instance, studies have demonstrated its potential in inhibiting enzymes involved in cancer progression. The butylamino group, in particular, plays a pivotal role in modulating the compound's binding affinity to biological targets, thereby enhancing its therapeutic efficacy.

The synthesis of Benzenesulfonamide,3-amino-4-(butylamino)- involves multi-step organic reactions that highlight the compound's synthetic versatility. Researchers have developed efficient synthetic pathways that leverage modern catalytic techniques to produce this sulfonamide derivative with high yield and purity. These advancements in synthetic methodologies have not only facilitated its production but also opened new avenues for exploring its derivatives.

One of the most compelling aspects of Benzenesulfonamide,3-amino-4-(butylamino)- is its role as a scaffold for drug discovery. Its rigid aromatic core and functionalizable side chains provide a unique platform for designing molecules with tailored biological activities. Recent computational studies have predicted that derivatives of this compound may exhibit potent activity against drug-resistant bacterial strains. This finding underscores the importance of sulfonamide derivatives in combating emerging infectious diseases.

The pharmacokinetic properties of Benzenesulfonamide,3-amino-4-(butylamino)- have also been thoroughly investigated. Studies indicate that this compound exhibits good oral bioavailability and moderate metabolic stability, making it a promising candidate for further development into an oral therapeutic agent. Additionally, its solubility profile suggests potential for formulation into injectable solutions, expanding its therapeutic applications.

In conclusion, Benzenesulfonamide,3-amino-4-(butylamino)- (CAS No. 1565-51-1) is a multifaceted compound with significant implications in pharmaceutical research. Its unique structural features and versatile reactivity make it an invaluable tool for drug discovery and development. As research continues to uncover new applications for this sulfonamide derivative, it is likely to play an increasingly important role in addressing various therapeutic challenges.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)